Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Dauch (AXL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Dauch (AXL) over the last 17 years, with Q4 2025 value amounting to $708.9 million.

  • Dauch's Cash & Equivalents rose 2821.49% to $708.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $708.9 million, marking a year-over-year increase of 2821.49%. This contributed to the annual value of $708.9 million for FY2025, which is 2821.49% up from last year.
  • Per Dauch's latest filing, its Cash & Equivalents stood at $708.9 million for Q4 2025, which was up 2821.49% from $714.1 million recorded in Q3 2025.
  • In the past 5 years, Dauch's Cash & Equivalents ranged from a high of $714.1 million in Q3 2025 and a low of $465.7 million during Q1 2023
  • In the last 5 years, Dauch's Cash & Equivalents had a median value of $530.0 million in 2022 and averaged $549.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 3421.02% in 2021, then surged by 3163.13% in 2025.
  • Dauch's Cash & Equivalents (Quarter) stood at $530.2 million in 2021, then fell by 3.53% to $511.5 million in 2022, then rose by 1.64% to $519.9 million in 2023, then increased by 6.35% to $552.9 million in 2024, then increased by 28.21% to $708.9 million in 2025.
  • Its Cash & Equivalents stands at $708.9 million for Q4 2025, versus $714.1 million for Q3 2025 and $586.5 million for Q2 2025.